AllianceBernstein
TNYA icon

AllianceBernstein’s Tenaya Therapeutics TNYA Stock Holding History

AllianceBernstein’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-49,570
Closed -$28.3K – 3333
2025
Q1 		$28.3K Hold
49,570
– – ﹤0.01% 3170
2024
Q4 		$70.9K Hold
49,570
– – ﹤0.01% 3162
2024
Q3 		$95.7K Hold
49,570
– – ﹤0.01% 3138
2024
Q2 		$154K Buy
49,570
+16,390
+49% +$67.7K ﹤0.01% 3069
2024
Q1 		$174K Hold
33,180
– – ﹤0.01% 2951
2023
Q4 		$108K Hold
33,180
– – ﹤0.01% 3061
2023
Q3 		$84.6K Hold
33,180
– – ﹤0.01% 3088
2023
Q2 		$195K Buy
+33,180
New +$193K ﹤0.01% 2989

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

AllianceBernstein's TNYA Position: Q2 2025 in Review

AllianceBernstein sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 49,570 shares — an estimated $28.3K sold.

AllianceBernstein first reported a position in TNYA in Q2 2023 and held it in 8 quarters. The position peaked at $195K in Q2 2023. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • AllianceBernstein reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 49,570 Tenaya Therapeutics shares in Q2 2025, an estimated $28.3K.
  • AllianceBernstein first reported a position in Tenaya Therapeutics in Q2 2023 and held it in 8 quarters.
  • AllianceBernstein's Tenaya Therapeutics position peaked at $195K in Q2 2023.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.